Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Guido Mastrobuoni is active.

Publication


Featured researches published by Guido Mastrobuoni.


Chemical Communications | 2007

ESI mass spectrometry and X-ray diffraction studies of adducts between anticancer platinum drugs and hen egg white lysozyme

Angela Casini; Guido Mastrobuoni; Claudia Temperini; Chiara Gabbiani; Simona Francese; Gloriano Moneti; Claudiu T. Supuran; Andrea Scozzafava; Luigi Messori

The interactions of cisplatin and its analogues, transplatin, carboplatin and oxaliplatin, with hen egg white lysozyme were analysed through ESI mass spectrometry, and the resulting metallodrug-protein adducts identified; the X-ray crystal structure of the cisplatin lysozyme derivative, solved at 1.9 A resolution, reveals selective platination of imidazole Nepsilon of His15.


Molecular Cell | 2011

In vivo and transcriptome-wide identification of RNA binding protein target sites.

Anna-Carina Jungkamp; Marlon Stoeckius; D. Mecenas; Dominic Grün; Guido Mastrobuoni; Stefan Kempa; Nikolaus Rajewsky

Animal mRNAs are regulated by hundreds of RNA binding proteins (RBPs). The identification of RBP targets is crucial for understanding their function. A recent method, PAR-CLIP, uses photoreactive nucleosides to crosslink RBPs to target RNAs in cells prior to immunoprecipitation. Here, we establish iPAR-CLIP (in vivo PAR-CLIP) to determine, at nucleotide resolution, transcriptome-wide binding sites of GLD-1, a conserved, germline-specific translational repressor in C. elegans. We identified 439 reproducible target mRNAs and demonstrate an excellent dynamic range of target detection by iPAR-CLIP. Upon GLD-1 knockdown, protein but not mRNA expression of the 439 targets was specifically upregulated, demonstrating functionality. Finally, we discovered strongly conserved GLD-1 binding sites near the start codon of target genes. These sites are functional in vitro and likely confer strong repression in vivo. We propose that GLD-1 interacts with the translation machinery near the start codon, a so-far-unknown mode of gene regulation in eukaryotes.


The EMBO Journal | 2012

Gene expression of pluripotency determinants is conserved between mammalian and planarian stem cells

Pinar Önal; Dominic Grün; Catherine Adamidi; Agnieszka Rybak; Jordi Solana; Guido Mastrobuoni; Yongbo Wang; Hans-Peter Rahn; Wei Chen; Stefan Kempa; Ulrike Ziebold; Nikolaus Rajewsky

Freshwater planaria possess extreme regeneration capabilities mediated by abundant, pluripotent stem cells (neoblasts) in adult animals. Although planaria emerged as an attractive in vivo model system for stem cell biology, gene expression in neoblasts has not been profiled comprehensively and it is unknown how molecular mechanisms for pluripotency in neoblasts relate to those in mammalian embryonic stem cells (ESCs). We purified neoblasts and quantified mRNA and protein expression by sequencing and shotgun proteomics. We identified ∼4000 genes specifically expressed in neoblasts, including all ∼30 known neoblast markers. Genes important for pluripotency in ESCs, including regulators as well as targets of OCT4, were well conserved and upregulated in neoblasts. We found conserved expression of epigenetic regulators and demonstrated their requirement for planarian regeneration by knockdown experiments. Post‐transcriptional regulatory genes characteristic for germ cells were also enriched in neoblasts, suggesting the existence of a common ancestral state of germ cells and ESCs. We conclude that molecular determinants of pluripotency are conserved throughout evolution and that planaria are an informative model system for human stem cell biology.


ChemMedChem | 2006

Exploring Metallodrug–Protein Interactions by ESI Mass Spectrometry: The Reaction of Anticancer Platinum Drugs with Horse Heart Cytochrome c

Angela Casini; Chiara Gabbiani; Guido Mastrobuoni; Luigi Messori; Gloriano Moneti; Giuseppe Pieraccini

Since DNA is commonly believed to be the primary target for platinum metallodrugs, researchers’ interest has mainly focused on the characterisation of platinum–nucleic acid adducts while devoting much less attention to platinum–protein adducts. However, protein-bound platinum fragments probably represent truly active anticancer species—rather than mere drug-inactivation products—provided that metal transfer among distinct binding sites is kinetically allowed. Moreover, platination of specific side chains, which can affect the function of biologically crucial proteins or enzymes through the formation of tight coordinative bonds, might play a relevant role in the overall mechanism and toxicity of platinum drugs. The state of the art of platinum–protein interactions is described in a few articles and reviews; in any case, this issue warrants further experimental work. Thanks to the latest improvements, electrospray ionisation mass spectrometry (ESI-MS) today represents a very powerful method for exploring metallodrug–protein interactions. Owing to the introduction of “soft” ionisation methods, it is possible to transfer the intact metal–protein adduct—whole, in the gas phase—to determine its molecular mass with high accuracy and, thus, obtain its full molecular characterisation. However, much work is still required for the optimisation and the standardisation of experimental ESI-MS procedures directed at these systems. A great variability in ESI-MS responses is generally found in the current literature that depends on many factors, such as the nature of the protein, the nature of the metal, the specific solution conditions, the nature of the metalbound ligands, pH and the kind of buffer. Apparently, the intrinsic “fragility” of the metal–protein coordination bonds represents a major obstacle, often leading to extensive bond cleavage during ionisation and to loss of chemical information. Some pioneering ESI-MS studies of platinum–protein interactions were reported a few years ago by Gibson and co-workers, who used either ubiquitin or myoglobin as model proteins. A number of platinum–protein adducts were identified and characterised in detail. Afterwards, a few additional ESI-MS studies of various metallodrug–protein adducts were reported by other research groups. Cytochrome c is a small electron-carrier heme protein, localised in the mitochondria, that plays a crucial role in apoptotic pathways. Cytochrome c is also known to be an excellent ESI-MS probe and has been the subject of a number of investigations. This led us to choose cytochrome c as the model protein for our study. The following classical platinum drugs were selected: cisplatin, transplatin, carboplatin and oxaliplatin (Scheme 1).


Chemical Senses | 2011

Odorant-Binding Proteins and Chemosensory Proteins in Pheromone Detection and Release in the Silkmoth Bombyx mori

Francesca R. Dani; Elena Michelucci; Simona Francese; Guido Mastrobuoni; Silvia Cappellozza; Giancarlo la Marca; Alberto Niccolini; Antonio Felicioli; Gloriano Moneti; Paolo Pelosi

The genome of the silkmoth Bombyx mori contains 44 genes encoding odorant-binding proteins (OBPs) and 20 encoding chemosensory proteins (CSPs). In this work, we used a proteomic approach to investigate the expression of proteins of both classes in the antennae of adults and in the female pheromone glands. The most abundant proteins found in the antennae were the 4 OBPs (PBP, GOBP1, GOBP2, and ABP) and the 2 CSPs (CSP1 and CSP2) previously identified and characterized. In addition, we could detect only 3 additional OBPs and 2 CSPs, with clearly different patterns of expression between the sexes. Particularly interesting, on the other hand, is the relatively large number of binding proteins (1 OBP and 7 CSPs) expressed in the female pheromone glands, some of them not present in the antennae. In the glands, these proteins could be likely involved in the solubilization of pheromonal components and their delivery in the environment.


ChemMedChem | 2007

ESI–MS Characterisation of Protein Adducts of Anticancer Ruthenium(II)‐Arene PTA (RAPTA) Complexes

Angela Casini; Guido Mastrobuoni; Wee Han Ang; Chiara Gabbiani; Giuseppe Pieraccini; Gloriano Moneti; Paul J. Dyson; Luigi Messori

Electrospray ionization mass spectrometry allows a rapid characterisation of the adducts formed between three novel anticancer ruthenium(II)-arene PTA compounds and horse heart cytochrome c or hen egg white lysozyme. Specific information on the nature of the protein-bound metallic fragments and the extent of protein metallation was readily obtained.


The Journal of Neuroscience | 2013

The Pro-Neurotrophin Receptor Sortilin Is a Major Neuronal Apolipoprotein E Receptor for Catabolism of Amyloid-β Peptide in the Brain

Anne Sophie Carlo; Camilla Gustafsen; Guido Mastrobuoni; Morten Nielsen; Tilman Burgert; Daniela Hartl; Michael Rohe; Anders Nykjaer; Joachim Herz; Joerg Heeren; Stefan Kempa; Claus Munck Petersen; Thomas E. Willnow

Apolipoprotein E (APOE) is the major risk factor for sporadic Alzheimers disease. Among other functions, APOE is proposed to sequester neurotoxic amyloid-β (Aβ) peptides in the brain, delivering them to cellular catabolism via neuronal APOE receptors. Still, the receptors involved in this process remain controversial. Here, we identified the pro-neurotrophin receptor sortilin as major endocytic pathway for clearance of APOE/Aβ complexes in neurons. Sortilin binds APOE with high affinity. Lack of receptor expression in mice results in accumulation of APOE and of Aβ in the brain and in aggravated plaque burden. Also, primary neurons lacking sortilin exhibit significantly impaired uptake of APOE/Aβ complexes despite proper expression of other APOE receptors. Despite higher than normal brain APOE levels, sortilin-deficient animals display anomalies in brain lipid metabolism (e.g., accumulation of sulfatides) seen in APOE-deficient mice, indicating functional deficiency in cellular APOE uptake pathways. Together, our findings identified sortilin as an essential neuronal pathway for APOE-containing lipoproteins in vivo and suggest an intriguing link between Aβ catabolism and pro-neurotrophin signaling converging on this receptor.


Combinatorial Chemistry & High Throughput Screening | 2009

MALDI Mass Spectrometry Imaging, from its Origins up to Today: The State of the Art

Simona Francese; Francesca R. Dani; Pietro Traldi; Guido Mastrobuoni; Giuseppe Pieraccini; Gloriano Moneti

Mass Spectrometry (MS) has a number of features namely sensitivity, high dynamic range, high resolution, and versatility which make it a very powerful analytical tool for a wide spectrum of applications spanning all the life science fields. Among all the MS techniques, MALDI Imaging mass spectrometry (MALDI MSI) is currently one of the most exciting both for its rapid technological improvements, and for its great potential in high impact bioscience fields. Here, MALDI MSI general principles are described along with technical and instrumental details as well as application examples. Imaging MS instruments and imaging mass spectrometric techniques other than MALDI, are presented along with examples of their use. As well as reporting MSI successes in several bioscience fields, an attempt is made to take stock of what has been achieved so far with this technology and to discuss the analytical and technological advances required for MSI to be applied as a routine technique in clinical diagnostics, clinical monitoring and in drug discovery.


Genome Biology | 2015

Extensive identification and analysis of conserved small ORFs in animals.

Sebastian D. Mackowiak; Henrik Zauber; Chris Bielow; Denise Thiel; Kamila Kutz; Lorenzo Calviello; Guido Mastrobuoni; Nikolaus Rajewsky; Stefan Kempa; Matthias Selbach; Benedikt Obermayer

BackgroundThere is increasing evidence that transcripts or transcript regions annotated as non-coding can harbor functional short open reading frames (sORFs). Loss-of-function experiments have identified essential developmental or physiological roles for a few of the encoded peptides (micropeptides), but genome-wide experimental or computational identification of functional sORFs remains challenging.ResultsHere, we expand our previously developed method and present results of an integrated computational pipeline for the identification of conserved sORFs in human, mouse, zebrafish, fruit fly, and the nematode C. elegans. Isolating specific conservation signatures indicative of purifying selection on amino acid (rather than nucleotide) sequence, we identify about 2,000 novel small ORFs located in the untranslated regions of canonical mRNAs or on transcripts annotated as non-coding. Predicted sORFs show stronger conservation signatures than those identified in previous studies and are sometimes conserved over large evolutionary distances. The encoded peptides have little homology to known proteins and are enriched in disordered regions and short linear interaction motifs. Published ribosome profiling data indicate translation of more than 100 novel sORFs, and mass spectrometry data provide evidence for more than 70 novel candidates.ConclusionsTaken together, we identify hundreds of previously unknown conserved sORFs in major model organisms. Our computational analyses and integration with experimental data show that these sORFs are expressed, often translated, and sometimes widely conserved, in some cases even between vertebrates and invertebrates. We thus provide an integrated resource of putatively functional micropeptides for functional validation in vivo.


BMC Genomics | 2012

Proteome dynamics and early salt stress response of the photosynthetic organism Chlamydomonas reinhardtii

Guido Mastrobuoni; Susann Irgang; Matthias Pietzke; Heike E Aßmus; Markus Wenzel; Waltraud X. Schulze; Stefan Kempa

BackgroundThe cellular proteome and metabolome are underlying dynamic regulation allowing rapid adaptation to changes in the environment. System-wide analysis of these dynamics will provide novel insights into mechanisms of stress adaptation for higher photosynthetic organisms. We applied pulsed-SILAC labeling to a photosynthetic organism for the first time and we established a method to study proteome dynamics in the green alga Chlamydomonas reinhardtii, an emerging model system for plant biology. In addition, we combined the analysis of protein synthesis with metabolic profiling to study the dynamic changes of metabolism and proteome turnover under salt stress conditions.ResultsTo study de novo protein synthesis an arginine auxotroph Chlamydomonas strain was cultivated in presence of stable isotope-labeled arginine for 24 hours. From the time course experiment in 3 salt concentrations we could identify more than 2500 proteins and their H/L ratio in at least one experimental condition; for 998 protiens at least 3 ratio counts were detected in the 24 h time point (0 mM NaCl). After fractionation we could identify 3115 proteins and for 1765 of them we determined their de novo synthesis rate. Consistently with previous findings we showed that RuBisCO is among the most prominent proteins in the cell; and similar abundance and turnover for the small and large RuBisCO subunit could be calculated. The D1 protein was identified among proteins with a high synthesis rates. A global median half-life of 45 h was calculated for Chlamydomonas proteins under the chosen conditions.ConclusionTo investigate the temporal co-regulation of the proteome and metabolome, we applied salt stress to Chlamydomonas and studied the time dependent regulation of protein expression and changes in the metabolome. The main metabolic response to salt stress was observed within the amino acid metabolism. In particular, proline was up-regulated manifold and according to that an increased carbon flow within the proline biosynthetic pathway could be measured. In parallel the analysis of abundance and de novo synthesis of the corresponding enzymes revealed that metabolic rearrangements precede adjustments of protein abundance.

Collaboration


Dive into the Guido Mastrobuoni's collaboration.

Top Co-Authors

Avatar

Stefan Kempa

Max Delbrück Center for Molecular Medicine

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Simona Francese

Sheffield Hallam University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Nikolaus Rajewsky

Max Delbrück Center for Molecular Medicine

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Chris Bielow

Free University of Berlin

View shared research outputs
Researchain Logo
Decentralizing Knowledge